A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study.

J Neurogastroenterol Motil · 2022 · PMC8978125 · PMID 35232894

Europe PMC DOI

hedged sentence

0.3010

closest p · 6.0× alpha

0.3010

boldest claim

The sentences

did not reach statistical significanceP = 0.301not close (p > 0.1)

Although the difference did not reach statistical significance the response rate was higher in the DA-9701 group than in the placebo group ( P = 0.301) ( Fig. 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.